Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20051
20061
20073
20083
20093
20112
20122
20133
20141
20151
20171
20181
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated7
Active, not recruiting2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
City of Hope Medical Center2
Columbia University2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
Northwestern University2
University of Nebraska2
University of Washington2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic33
Hodgkin Disease20
Immunoblastic Lymphadenopathy19
Lymphoma, Large B-Cell, Diffuse18
Lymphoma, Follicular16
Lymphoma, Mantle-Cell16
Lymphoma, Non-Hodgkin16
Burkitt Lymphoma15
Lymphoma15
Lymphoma, B-Cell, Marginal Zone15

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.